Millipore Sigma Vibrant Logo

553031 RAGE Antagonist Peptide, RAP - Calbiochem

The RAGE Antagonist Peptide, RAP controls the biological activity of RAGE.

RAGE Antagonist Peptide, RAP - Calbiochem: MSDS (material safety data sheet) o SDS, certificato d’analisi (CoA) e certificato di qualità (CoQ), dossier, brochure e altri documenti disponibili.

Sinonimi: ELKVLMEKEL

Primary Target: RAGE
View Products on Sigmaaldrich.com
553031
Visualizza prezzi e disponibilità

Panoramica

Replacement Information

Tabella delle specifiche principali

Empirical Formula
C₅₇H₁₀₁N₁₃O₁₇S

Prezzi e disponibilità

Numero di catalogo DisponibilitàConfezionamento Qtà/conf Prezzo Quantità
553031-10MG
Verifica della disponibilità in corso...
—
Disponibilità limitata Disponibilità limitata
A magazzino 
Fuori produzione
Disponibili quantità limitate
La disponibilità deve essere confermata
    Prodotti rimanenti: riceverà un nostro avviso
      Prodotti rimanenti: riceverà un nostro avviso
      Will advise
      Contatti il Servizio Clienti
      Contact Customer Service

      		 Bottiglia di vetro 10 mg
      Ricerca del prezzo in corso...
      Non è stato possibile trovare il prezzo
      La quantità minima deve essere un multiplo di
      Maximum Quantity is
      Al termine dell'ordine Maggiori informazioni
      Lei ha salvato ()
       
      —
      Richiedi il prezzo
      		 —
      Description
      OverviewAn S100P-derived peptide based competitive antagonist for receptor for advanced glycation end product (RAGE). Shown to disrupt the interaction between RAGE and its ligands, such as S100P, S100A4 and HMGB-1 in binding assays and in multiple cancer cell lines (~2 µM). Also, blocks RAGE-dependent NF-kB activation in MPanc96, MOH and HPAF II tumor cell lines. Systemic administration of RAP also diminishes NF-kB signaling in vivo and significantly reduces glioma tumor growth in murine models.
      Catalogue Number553031
      Brand Family Calbiochem®
      SynonymsELKVLMEKEL
      References
      ReferencesArumugam, T., et al. 2012. Clin Cancer Res. 18, 4356.
      Product Information
      FormWhite powder
      FormulationSupplied as a trifluoroacetate salt.
      Hill FormulaC₅₇H₁₀₁N₁₃O₁₇S
      ReversibleY
      Quality LevelMQ200
      Applications
      Biological Information
      Primary TargetRAGE
      Primary Target IC<sub>50</sub>2 µ
      Purity≥95% by HPLC
      Physicochemical Information
      Peptide SequenceAc-ELKVLMEKEL-NH2
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Storage and Shipping Information
      Ship Code Shipped at Ambient Temperature or with Blue Ice or with Dry Ice
      Toxicity Standard Handling
      Storage -20°C
      Protect from Light Protect from light
      Do not freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Packaging Information
      Packaged under inert gas Packaged under inert gas
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Numero di catalogo GTIN
      553031-10MG 04055977193473

      Documentation

      RAGE Antagonist Peptide, RAP - Calbiochem MSDS

      Titolo

      Scheda di sicurezza (MSDS) 

      RAGE Antagonist Peptide, RAP - Calbiochem Certificati d'Analisi

      TitoloNumero di lotto
      553031

      Riferimenti bibliografici

      Panoramica delle referenze
      Arumugam, T., et al. 2012. Clin Cancer Res. 18, 4356.
      Scheda tecnica

      Note that this data sheet is not lot-specific and is representative of the current specifications for this product. Please consult the vial label and the certificate of analysis for information on specific lots. Also note that shipping conditions may differ from storage conditions.

      Revision30-October-2012 JSW
      SynonymsELKVLMEKEL
      DescriptionAn S100P-derived peptide based competitive antagonist for receptor for advanced glycation end product (RAGE). Shown to disrupt the interaction between RAGE and its ligands, such as S100P, S100A4 and HMGB-1 in binding assays and in multiple cancer cell lines (~2 µM). Also, blocks RAGE-dependent NF-kB activation in MPanc96, MOH and HPAF II tumor cell lines. Systemic administration of RAP also diminishes NF-kB signaling in vivo and significantly reduces glioma tumor growth in murine models.
      FormWhite powder
      FormulationSupplied as a trifluoroacetate salt.
      Intert gas (Yes/No) Packaged under inert gas
      Peptide SequenceAc-ELKVLMEKEL-NH2
      Purity≥95% by HPLC
      SolubilityH₂O (5 mg/ml)
      Storage Protect from light
      -20°C
      Do Not Freeze Ok to freeze
      Special InstructionsFollowing reconstitution, aliquot and freeze (-20°C). Stock solutions are stable for up to 3 months at -20°C.
      Toxicity Standard Handling
      ReferencesArumugam, T., et al. 2012. Clin Cancer Res. 18, 4356.